Published in Cancer Res on September 01, 1999
Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A (2010) 6.10
Two-stage two-locus models in genome-wide association. PLoS Genet (2006) 5.60
Little epistasis for anxiety-related measures in the DeFries strains of laboratory mice. Mamm Genome (2004) 1.18
A two-locus system controls susceptibility to colitis-associated colon cancer in mice. Oncotarget (2010) 0.88
Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain. Carcinogenesis (2012) 0.82
Genetics of schizophrenia: from animal models to clinical studies. J Psychiatry Neurosci (2002) 0.81
Mapping six new susceptibility to colon cancer (Scc) loci using a mouse interspecific backcross. G3 (Bethesda) (2012) 0.80
Most lung and colon cancer susceptibility genes are pair-wise linked in mice, humans and rats. PLoS One (2011) 0.79
Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. Hum Hered (2011) 0.79
Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility. Cancer Immunol Immunother (2010) 0.78
Colitis-associated colon cancer: Is it in your genes? World J Gastroenterol (2015) 0.77
Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years. Cold Spring Harb Protoc (2015) 0.76
Genetic interactions with sex make a relatively small contribution to the heritability of complex traits in mice. PLoS One (2014) 0.76
Glucose tolerance female-specific QTL mapped in collaborative cross mice. Mamm Genome (2016) 0.75
Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet (1996) 3.60
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet (2008) 3.35
Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet (1996) 2.84
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2000) 2.63
Elucidation of the structure of methanopterin, a coenzyme from Methanobacterium thermoautotrophicum, using two-dimensional nuclear-magnetic-resonance techniques. Eur J Biochem (1984) 1.66
Identification of Ss protein as murine C4. Nature (1975) 1.63
Hepatocellular carcinoma in Txnip-deficient mice. Oncogene (2006) 1.31
Susceptibility to tuberculosis as a complex genetic trait: analysis using recombinant congenic strains of mice. Novartis Found Symp (1998) 1.28
Effects of freezing and freeze-drying on the biomechanical properties of rat bone. J Orthop Res (1984) 1.27
The recombinant congenic strains for analysis of multigenic traits: genetic composition. FASEB J (1992) 1.26
Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst (2001) 1.24
Genetic composition of the recombinant congenic strains. Mamm Genome (1996) 1.22
Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun (2000) 1.12
Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat Genet (1998) 1.05
Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene (1992) 1.04
Revised nomenclature of mouse H-2 genes. Immunogenetics (1990) 1.03
High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14. Cancer Res (1998) 1.01
Resistance to Leishmania major in mice. Science (1996) 0.99
Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci U S A (1996) 0.97
Methods to detect CNVs in the human genome. Cytogenet Genome Res (2009) 0.94
Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice. Genes Immun (2002) 0.93
Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun (2006) 0.93
Characterization of wild-type and mutant M13 gene V proteins by means of 1H-NMR. Eur J Biochem (1991) 0.91
The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse. Mamm Genome (1991) 0.91
Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs. Cancer Res (1988) 0.91
Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice. Infect Immun (2005) 0.90
Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants. J Immunol (1984) 0.88
Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains. Int J Cancer (1999) 0.86
Different genetic susceptibility to aberrant crypts and colon adenomas in mice. Cancer Res (1996) 0.85
Regulation of expression of mouse C4 and Slp genes by non-H-2-linked genes. Immunogenetics (1989) 0.83
The production of two Th2 cytokines, interleukin-4 and interleukin-10, is controlled independently by locus Cypr1 and by loci Cypr2 and Cypr3, respectively. Immunogenetics (1999) 0.83
IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics (1997) 0.82
Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL. Mamm Genome (2001) 0.82
Mouse genetic model for antigen-induced airway manifestations of asthma. Genes Immun (2006) 0.82
Structure of the DNA binding wing of the gene-V encoded single- stranded DNA binding protein of the filamentous bacteriophage M13. FEBS Lett (1990) 0.82
The immunogenetics of susceptibility and resistance to murine experimental allergic orchitis. Reg Immunol (1993) 0.81
Common SNPs in LEP and LEPR associated with birth weight and type 2 diabetes-related metabolic risk factors in twins. Int J Obes (Lond) (2008) 0.81
Mapping of genes controlling quantitative antibody production in Biozzi mice. J Immunol (1995) 0.81
Identification and expression of the Tla region gene T11b and its Qa-like product. J Immunol (1990) 0.80
Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis. Blood (2001) 0.80
Identification of differentially regulated genes in mildly hyperlipidemic ApoE3-Leiden mice by use of serial analysis of gene expression. Arterioscler Thromb Vasc Biol (2001) 0.80
MHC-controlled susceptibility to C3H-MTV-induced mouse mammary tumors is predominantly systemic rather than local. Int J Cancer (1987) 0.79
Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1). Oncogene (1999) 0.79
Segregation of genes from donor strain during the production of recombinant congenic strains. Lab Anim (1991) 0.79
A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex. Immunogenetics (1995) 0.79
A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA. Genes Immun (2000) 0.79
Apoptosis susceptibility genes on mouse chromosome 9 (Rapop2) and chromosome 3 (Rapop3). Genomics (1995) 0.78
Genetic dissection of susceptibility to radiation-induced apoptosis of thymocytes and mapping of Rapop1, a novel susceptibility gene. Genomics (1995) 0.78
T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse chromosomes 7 and 9. Mamm Genome (1999) 0.78
Fetal mouse alveolar type II cells in culture express several type II cell characteristics found in vivo, together with major histocompatibility antigens. Am J Respir Cell Mol Biol (1990) 0.78
Fine mapping of the crossover-sites in the C4-H-2D region of H-2 recombinant mouse strains. Immunogenetics (1991) 0.78
Haplotype-specific interactions of non-H-2-linked genetic factors controlling the mouse C4 and Slp protein levels. Genetics (1989) 0.78
A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4. Cancer Res (1995) 0.78
Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2. Immunogenetics (1996) 0.78
Simulation of the distribution of parental strains' genomes in RC strains of mice. Mamm Genome (1997) 0.78
Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics (1995) 0.78
Trans-regulatory genes affect Slpa and Slpo expression and act in a tissue-specific manner. Immunogenetics (1989) 0.78
Three-dimensional patterns of lung tumor growth: association with tumor heterogeneity. Exp Lung Res (2001) 0.78
Relationships between private and public specificities controlled by the H-2D region. Transplant Proc (1977) 0.77
Large scale mtDNA sequencing reveals sequence and functional conservation as major determinants of homoplasmic mtDNA variant distribution. Mitochondrion (2011) 0.77
T-cell proliferative response is controlled by locus Tria3 on mouse chromosome 17. Immunogenetics (1999) 0.77
Histocompatibility and the genetics of tumour resistance. J Immunogenet (1987) 0.77
A novel alloreactivity-controlling locus, Alan1, mapped to mouse chromosome 17. Immunogenetics (2000) 0.76
Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. Immunogenetics (1996) 0.76
Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting Susceptibility to lung cancer (Sluc) genes with large effects. Exp Lung Res (1998) 0.75
Mutants of Pseudomonas aeruginosa unable to inactivate allantoinase and NADP-dependent glutamate dehydrogenase. Arch Microbiol (1984) 0.75
Differential effects of bacterial lipopolysaccharides upon neutrophil function. FEBS Lett (1998) 0.75
Multiple genes in the H-2 complex affect differently the number and growth rate of transplacentally induced lung tumours in mice. Int J Cancer (1983) 0.75
Genetics of susceptibility to radiation-induced apoptosis in colon: two loci on chromosomes 9 and 16. Mamm Genome (1998) 0.75
New Ly-6 congenic strains. Immunogenetics (1987) 0.75
The defect in the AT-like hamster cell mutants is complemented by mouse chromosome 9 but not by any of the human chromosomes. Mutat Res (1996) 0.75
Capping experiments fail to reveal H-2Rd molecules in Dd region. Transplant Proc (1983) 0.75
[Proceedings: Private and public specificities of the H-2 system in the lymphocyte membrane]. Ann Immunol (Paris) (1975) 0.75
Interrelations between private and public specificities controlled by D region of H-2 complex [proceedings]. Folia Biol (Praha) (1976) 0.75
Histocompatibility antigens in wild mice (Mus musculus). Transplant Proc (1969) 0.75
Allele-specific occurrence of multiple C4 and Slp mRNAs. Tissue Antigens (1989) 0.75
Antigens of the Qa-2 family exhibit differential cellular expression. Transplant Proc (1987) 0.75
Resistance to Leishmania major in Mice. Science (1996) 0.75
A new Tla region antigen Qa-11, similar to Qa-2 and associated with B-type beta 2-microglobulin. J Immunol (1985) 0.75
Further evidence for two separate loci (H-2D and H-2L) in the D region of the H-2 complex. Transplant Proc (1979) 0.75
Antigenic characterization of products of cloned H-2b genes. Transplant Proc (1983) 0.75
MHC and non-MHC genes in lung tumor susceptibility in the mouse: implications for the study of the different lung tumor types and their cell of origin. Exp Lung Res (1991) 0.75
Altered expression of MHC products on AKR lymphoma cells. Transplant Proc (1983) 0.75
Correlation between quantitative expression of H-2K, H-2D and MuLV antigens on spontaneous AKR lymphomas. Int J Cancer (1986) 0.75
Qa-12--a novel determinant of activated T and B lymphocytes. J Immunogenet (1990) 0.75
Genetic linkage of nuclear morphology of mouse lung tumors to the Kras-2 locus. Exp Lung Res (2001) 0.75
Loss of heterozygosity on chromosome 5 in vicinity of the telomere in gamma-radiation-induced thymic lymphomas in mice. Neoplasma (2000) 0.75
Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse--an evaluation. Oncogene (1994) 0.75
Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex. J Natl Cancer Inst (1989) 0.75
Effects of the MHC on hormonal induction of mammary tumors and function of hypophyseal isografts in the mouse. Immunogenetics (1990) 0.75
H-2L locus: alleles, products, and specificities. Transplant Proc (1979) 0.75
Molecular basis of Qa-11 antigen and paradoxical Qa-gene expression in an H-2 recombinant. J Immunol (1989) 0.75
Derivation of tumorigenic and non-tumorigenic mouse alveolar type-II cell lines from fetal type-II cells after a combined in vivo/in vitro carcinogen treatment. Int J Cancer (1992) 0.75
Histocompatibility antigens, tumours and viruses. J Immunogenet (1980) 0.75